Table 2.
Characteristic | LSIL Outcome | P Value | |
---|---|---|---|
Progression to HSIL (n = 69) | LSIL or Benign Epithelium (n = 99) |
||
Age, y, mean (range) | 44 (22–65) | 44 (21–73) | .9 |
Gender | |||
Male | 66 (43) | 88 (57) | .1 |
Female | 3 (21) | 11 (79) | |
Race/Ethnicity | |||
White | 34 (49) | 38 (38) | .3 |
African American | 12 (17) | 25 (25) | |
Hispanic | 21 (30) | 29 (29) | |
Other | 2 (3) | 7 (7) | |
Smoking history | |||
Current | 14 (20) | 20 (20) | .5 |
Former | 20 (29) | 21 (21) | |
Never | 35 (51) | 58 (59) | |
HIV status | |||
Infected (n = 146) | 65 (45) | 81 (55) | .02 |
Uninfected (n = 22) | 4 (18) | 18 (82) | |
CD4+ T-cell count, cells/mm3 | (n=65) | (n=81) | |
<1000 | 57 (88) | 68 (84) | .5 |
≥1000 | 8 (12) | 13 (16) | |
HIV RNA load, copies/mL | (n=65) | (n=81) | |
<100 | 48 (74) | 67 (83) | .2 |
≥100 | 17 (26) | 14 (17) |
Data are presented as number of cases (percentage) unless otherwise indicated.
Abbreviations: HIV, human immunodeficiency virus; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion.